CovAbTM Antibody Test
The CovAb™ SARS-CoV-2 Antibody Test is a lateral-flow immunoassay intended for the qualitative detection of total antibody (including IgG, IgA and IgM) to SARS-CoV-2 in oral fluid from patients with suspected COVID-19 infection. The CovAb™ SARS-CoV-2 Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection, or vaccination.
The CovAb™ SARS-CoV-2 Antibody Test is distributed and sold in the USA domestic market.
SARS-CoV-2 Antibody Test
CovAb™ is a rapid Covid-19 antibody test with the following features:
- Saliva based – non invasive;
- Rapid results – 15 minutes;
- 97.6% sensitivity / 98.8% specificity*;
- Detects all 3 antibody classes (IgA, IgG, and IgM);
- FDA Emergency Use Authorization;
- Made in the USA.
*>15 days from onset of symptoms.
CovAb™ Documents
Instructions for use Kit (IFU)
Instructions for use Controls (IFU)
Fact sheet for healthcare providers
(Brochure 1 | Brochure 2)
